A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer
Condition:   Epithelial Ovarian Cancer Intervention:   Drug: Envafolimab Sponsor:   Hebei Medical University Fourth Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
Conditions:   Ovarian High Grade Serous Adenocarcinoma;   Platinum-Resistant Ovarian Carcinoma Interventions:   Drug: Atovaquone;   Procedure: Biopsy;   Procedure: Computed Tomography;   Procedure: Paracentesis Sponsors:   Emory University;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials